Articles by Andrew M. Tershakovec (13)

Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia

Adrian Dobs, Michael Miller, Paul T. DeLucca, Karen E. Ramsey, Andrew M. Tershakovec and Wendy Horn

Journal of Clinical Lipidology 2 ( 1 ): 12 - 18 , 2008

Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes

Ruth S. Weinstock, Ronald B. Goldberg, John R. Guyton, Theodore Mazzone, Adam Polis, Joanne E. Tomassini, Jianxin Lin, Arvind Shah and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 1 ): 25 - 35 , 2008

Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetes

John R. Guyton, Ronald B. Goldberg, Theodore Mazzone, Ruth S. Weinstock, Adam Polis, Elizabeth Rosenberg and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 1 ): 19 - 24 , 2008

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses

Nicola Abate, Alberico L. Catapano, Christie M. Ballantyne, Michael H. Davidson, Adam Polis, Steven S. Smugar and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 2 ): 91 - 105 , 2008

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein

Michael H. Davidson, Nicola Abate, Christie M. Ballantyne, Alberico L. Catapano, Xia Xu, Jianxin Lin, Elizabeth Rosenberg and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 6 ): 436 - 446 , 2008

Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients

JoAnne M. Foody, Shiva G. Sajjan, X. Henry Hu, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, Joanne E. Tomassini, Chuck Wentworth and Kaan Tunceli

Journal of Clinical Lipidology 4 ( 2 ): 126 - 132 , 2010

Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients

Kaan Tunceli, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu, Joanne E. Tomassini and JoAnne M. Foody

Journal of Clinical Lipidology 4 ( 6 ): 491 - 500 , 2010

Changes in Lipoprotein-associated Phospholipase A2 with Ezetimibe/Simvastatin Co-administered with ER Niacin in Type II Hyperlipidemia

Ngoc-Anh Le, Monica Farkas-Epperson, Ran Jin, Andrew M. Tershakovec, David R. Neff, Robert Wolfert, Joanne E. Tomassini and Peter Wilson

Journal of Clinical Lipidology 6 ( 3 ): 253 - 254 , 2012

Changes in Lipoprotein Particle Number with Ezetimibe/Simvastatin Co-administered with Extended-Release Niacin in Patients with Type II Hyperlipidemia

Ngoc-Anh Le, Ran Jin, Andrew M. Tershakovec, David R. Neff, Joanne E. Tomassini, James Otvos and Peter Wilson

Journal of Clinical Lipidology 6 ( 3 ): 254 - 255 , 2012

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome

Jennifer G. Robinson, Christie M. Ballantyne, Willa A. Hsueh, Jeffrey B. Rosen, Jianxin Lin, Arvind K. Shah, Joanne E. Tomassini, Robert S. Lowe and Andrew M. Tershakovec

Journal of Clinical Lipidology 7 ( 4 ): 292 - 303 , 2013

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction

Peter P. Toth, Christie M. Ballantyne, Michael H. Davidson, Joanne E. Tomassini, Dena Rosen Ramey, David Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 6 ( 2 ): 180 - 191 , 2012

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

Jennifer G. Robinson, Christie M. Ballantyne, Willa Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Shah, Robert S. Lowe, Mary E. Hanson and Andrew M. Tershakovec

Journal of Clinical Lipidology 5 ( 6 ): 474 - 482 , 2011

Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease

Peter P. Toth, JoAnne M. Foody, Joanne E. Tomassini, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu and Kaan Tunceli

Journal of Clinical Lipidology 8 ( 1 ): 107 - 116 , 2014

Do you have a suggestion for journals

Suggest Journal